title: Gefitinib in patients with non-small cell lung cancer: symptomatic improvement within a few days.
authors.forename: A
authors.initials: A
authors.lastname: Bearz
authors.forename: E
authors.initials: E
authors.lastname: Vaccher
authors.forename: S
authors.initials: S
authors.lastname: Spazzapan
authors.forename: M
authors.initials: M
authors.lastname: Berretta
authors.forename: U
authors.initials: U
authors.lastname: Tirelli
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D018450:Disease Progression; D005260:Female; D000077156:Gefitinib; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D011799:Quinazolines / Q000627:therapeutic use*; D016879:Salvage Therapy; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D000970:Antineoplastic Agents; D011799:Quinazolines; D000077156:Gefitinib